FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281392294> ?p ?o ?g. }

• W4281392294 endingPage "5394" @default.
• W4281392294 startingPage "5382" @default.
• W4281392294 abstract "Abstract Multiple sclerosis (MS) is a chronic and progressive neurological disease that is characterized by neuroinflammation, demyelination and neurodegeneration occurring from the earliest phases of the disease and that may be underestimated. MS patients accumulate disability through relapse-associated worsening or progression independent of relapse activity. Early intervention with high-efficacy disease-modifying therapies (HE-DMTs) may represent the best window of opportunity to delay irreversible central nervous system damage and MS-related disability progression by hindering underlying heterogeneous pathophysiological processes contributing to disability progression. In line with this, growing evidence suggests that early use of HE-DMTs is associated with a significant greater reduction not only of inflammatory activity (clinical relapses and new lesion formation at magnetic resonance imaging) but also of disease progression, in terms of accumulation of irreversible clinical disability and neurodegeneration compared to delayed HE-DMT use or escalation strategy. These beneficial effects seem to be associated with acceptable long-term safety risks, thus configuring this treatment approach as that with the most positive benefit/risk profile. Accordingly, it should be mandatory to treat people with MS early with HE-DMTs in case of prognostic factors suggestive of aggressive disease, and it may be advisable to offer an HE-DMT to MS patients early after diagnosis, taking into account drug safety profile, disease severity, clinical and/or radiological activity, and patient-related factors, including possible comorbidities, family planning, and patients’ preference in agreement with the EAN/ECTRIMS and AAN guidelines. Barriers for an early use of HE-DMTs include concerns for long-term safety, challenges in the management of treatment initiation and monitoring, negative MS patients’ preferences, restricted access to HE-DMTs according to guidelines and regulatory rules, and sustainability. However, these barriers do not apply to each HE-DMT and none of these appear insuperable." @default.
• W4281392294 created "2022-05-25" @default.
• W4281392294 creator A5001899447 @default.
• W4281392294 creator A5003010065 @default.
• W4281392294 creator A5023725739 @default.
• W4281392294 creator A5026026352 @default.
• W4281392294 creator A5036886301 @default.
• W4281392294 creator A5062775755 @default.
• W4281392294 creator A5066879414 @default.
• W4281392294 creator A5067412910 @default.
• W4281392294 creator A5083385630 @default.
• W4281392294 creator A5088924447 @default.
• W4281392294 date "2022-05-24" @default.
• W4281392294 modified "2023-10-18" @default.
• W4281392294 title "Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion" @default.
• W4281392294 cites W1567125068 @default.
• W4281392294 cites W1965976393 @default.
• W4281392294 cites W1969129043 @default.
• W4281392294 cites W1977742425 @default.
• W4281392294 cites W2003539800 @default.
• W4281392294 cites W2013234597 @default.
• W4281392294 cites W2051274614 @default.
• W4281392294 cites W2123968065 @default.
• W4281392294 cites W2130844101 @default.
• W4281392294 cites W2136756445 @default.
• W4281392294 cites W2164581953 @default.
• W4281392294 cites W2170005161 @default.
• W4281392294 cites W2171614089 @default.
• W4281392294 cites W2172431827 @default.
• W4281392294 cites W2320749905 @default.
• W4281392294 cites W2463810424 @default.
• W4281392294 cites W2464491214 @default.
• W4281392294 cites W2489242797 @default.
• W4281392294 cites W2512303823 @default.
• W4281392294 cites W2530962812 @default.
• W4281392294 cites W2544079919 @default.
• W4281392294 cites W2555514711 @default.
• W4281392294 cites W2561881161 @default.
• W4281392294 cites W2562276035 @default.
• W4281392294 cites W2586480138 @default.
• W4281392294 cites W2610990451 @default.
• W4281392294 cites W2614808368 @default.
• W4281392294 cites W2618423461 @default.
• W4281392294 cites W2736231139 @default.
• W4281392294 cites W2783703447 @default.
• W4281392294 cites W2787204655 @default.
• W4281392294 cites W2800924304 @default.
• W4281392294 cites W2888056765 @default.
• W4281392294 cites W2896912757 @default.
• W4281392294 cites W2902699417 @default.
• W4281392294 cites W2908373864 @default.
• W4281392294 cites W2910867209 @default.
• W4281392294 cites W2916478209 @default.
• W4281392294 cites W2934202790 @default.
• W4281392294 cites W2935777701 @default.
• W4281392294 cites W2982057636 @default.
• W4281392294 cites W3006577702 @default.
• W4281392294 cites W3008600501 @default.
• W4281392294 cites W3009870200 @default.
• W4281392294 cites W3012517977 @default.
• W4281392294 cites W3014272379 @default.
• W4281392294 cites W3016860584 @default.
• W4281392294 cites W3020371659 @default.
• W4281392294 cites W3026037032 @default.
• W4281392294 cites W3033592986 @default.
• W4281392294 cites W3033968144 @default.
• W4281392294 cites W3037496544 @default.
• W4281392294 cites W3046743814 @default.
• W4281392294 cites W3089971162 @default.
• W4281392294 cites W3102446918 @default.
• W4281392294 cites W3127250794 @default.
• W4281392294 cites W3129382481 @default.
• W4281392294 cites W3137339880 @default.
• W4281392294 cites W3138003291 @default.
• W4281392294 cites W3143335972 @default.
• W4281392294 cites W3162193517 @default.
• W4281392294 cites W3170708887 @default.
• W4281392294 cites W3177148104 @default.
• W4281392294 cites W3193714945 @default.
• W4281392294 cites W3194394721 @default.
• W4281392294 cites W3198197412 @default.
• W4281392294 cites W3198774415 @default.
• W4281392294 cites W3204456994 @default.
• W4281392294 cites W3204899114 @default.
• W4281392294 cites W3211371924 @default.
• W4281392294 cites W4206508748 @default.
• W4281392294 cites W4210695280 @default.
• W4281392294 cites W4211048507 @default.
• W4281392294 cites W4307582098 @default.
• W4281392294 cites W4376848271 @default.
• W4281392294 doi "https://doi.org/10.1007/s00415-022-11193-w" @default.
• W4281392294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35608658" @default.
• W4281392294 hasPublicationYear "2022" @default.
• W4281392294 type Work @default.
• W4281392294 citedByCount "14" @default.
• W4281392294 countsByYear W42813922942022 @default.
• W4281392294 countsByYear W42813922942023 @default.
• W4281392294 crossrefType "journal-article" @default.

• next